SCHEMBL6280923

SCHEMBL6280923

COc1ccc2[nH]c3c(c2c1)CCN(OC(C)=O)C31CCN(CCOc2ccccc2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 9/20 0.46
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPKAPK2 P49137 2/20 0.41
ATM Q13315 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRNA4 P43681 1/20 0.40
KDR P35968 1/20 0.40
TRPA1 O75762 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
DRD2 P14416 2/20 0.40
DRD3 P35462 2/20 0.40
OPRM1 P35372 1/20 0.40
OPRL1 P41146 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6496428 0.89 CFTR (0.47) CFTRKDM4EMEN1KMT2ANPSR1
SCHEMBL6504965 0.88 CFTR (0.53) CFTRKDM4EMEN1KMT2ANPSR1
Acetic Acid SCHEMBL6502120 0.87 CFTR (0.46) CFTRKDM4EMEN1KMT2ANPSR1
SCHEMBL6496683 0.87 CFTR (0.46) CFTRKDM4EMEN1KMT2ANPSR1
SCHEMBL6277839 0.87 CFTR (0.47) CFTRKDM4EMEN1KMT2ANPSR1
SCHEMBL6278814 0.87 CFTR (0.51) CFTRKDM4EMEN1KMT2ANPSR1
SCHEMBL6280476 0.86 CFTR (0.47) CFTRKDM4EMEN1KMT2ANPSR1
SCHEMBL6278853 0.86 CFTR (0.46) CFTRKDM4EMEN1KMT2ANPSR1
SCHEMBL6280736 0.85 CFTR (0.47) CFTRKDM4EMEN1KMT2ANPSR1
SCHEMBL6280325 0.85 CFTR (0.44) CFTRKDM4EMEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005048916-A2 TETRAHYDROSPIRO-BETA-CARBOLINE-1,3 '-PYRROLIDINE DERIVATIVES AND THEIR USE IN GHSR-RELATED DISORDERS BIOVITRUM AB (SE) 2005-06-02 WO disclosed